Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin. [electronic resource]
Producer: 20101008Description: 315-21 p. digitalISSN:- 1099-1387
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Doxorubicin -- administration & dosage
- Drug Carriers -- chemistry
- Drug Delivery Systems -- methods
- Endothelial Cells
- Humans
- Liposomes -- therapeutic use
- Mice
- Mice, Nude
- Molecular Mimicry
- Neovascularization, Pathologic -- drug therapy
- Thrombospondins -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.